HRTX FY 2025 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HRTXHeron Therapeutics, Inc.

$162M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$155M+7.4% YoY

Gross Profit

$114M73.3% margin

Operating Income

-$3M-1.6% margin

Net Income

-$20M-13.0% margin

EPS (Diluted)

$-0.12

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$28M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$256M

Total Liabilities

$242M

Stockholders' Equity

$14M

Cash & Equivalents

$29M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$155M	$144M	+7.4%
Gross Profit	$114M	$106M	+7.5%
Operating Income	-$3M	-$12M	+78.0%
Net Income	-$20M	-$14M	-48.7%